ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies
March 15, 2018Arsanis, Inc. today announced that the United States Patent and Trademark Office ("USPTO") issued U.S. -
AC Immune finds new antibodies targeting neurodegenerative diseases
August 24, 2017Swiss clinical stage biopharmaceutical company AC Immune has discovered new antibodies against two targets, Alpha-synuclein and TDP-43, in the pathogenesis of neurodegenerative diseases. -
Cell-Penetrating antibodies to oncogenic RAS show anti-tumor activity
May 31, 2017The technology is being further developed by Orum Therapeutics -
BioInvent expands manufacturing facility with Mobius bioreactors from Merck
April 24, 2017Fully scalable system streamlines drug development and production. -
XO1 Founding Management Team Re-Unite to Launch SuperX and Announce $11m Series A Funding With Medic
February 10, 2017SuperX Ltd, a biopharmaceutical company based in Cambridge, UK, announced today it has completed an $11m Series A investment led by Medicxi to develop antibodies with anticoagulant properties. -
Immune Pharma Enters a Research Partnership
January 25, 2017Will develop mono- and bispecific antibodies against tumors
Pharma Sources Insight January 2025
